Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

Volume XXX, Number 17 - December 4, 2023

December 4, 2023, Intelligence: Late-Breaking Lab News

You may have thought that the long-running saga of the now-defunct Theranos had ended. But no, there is continuing litigation in the Grand Canyon State. A class action suit—In re Arizona Theranos, Inc., Litigation, Case No. 2:16-cv-2138—continues to move forward in the U.S. District Court for the District of Arizona. This class action suit has […]

To access this post, you must purchase The Dark Report.

December 4, 2023, Intelligence: Late-Breaking Lab News Read More »

Payers Are Right to Be Wary of Claims for Some LDTs’ Value

EDITOR’S NOTE: Our column, Virchow, is written by anonymous insiders working within the managed care world. The column aims to help clients of The Dark Report better understand the decisions, policies, and actions of payers as they manage their laboratory networks, establish coverage guidelines, process lab test claims, and audit labs. THERE’S PLENTY OF NOISE

To access this post, you must purchase The Dark Report.

Payers Are Right to Be Wary of Claims for Some LDTs’ Value Read More »

CLIA Lab Directors Must Watch Delegated Duties

CEO SUMMARY: Laboratory accreditors warn that underestimating or overlooking the duties of a lab director can lead to citations during CLIA inspections. Presented here are the most-frequently cited violations of the CLIA lab director’s duties and responsibilities as documented during lab inspections conducted in 2022 by CAP, COLA, TJC, and A2LA. Editor’s note: This is

To access this post, you must purchase The Dark Report.

CLIA Lab Directors Must Watch Delegated Duties Read More »

Artificial Intelligence: Now a Priority for Labs

CEO SUMMARY: It’s time to recognize the field of artificial Intelligence as the next major source of disruption. Not only will clinical laboratories, anatomic pathology groups, and diagnostics companies be disrupted by AI-powered technologies, but experts predict that almost every area of daily life may be transformed in some manner as artificial intelligence becomes more

To access this post, you must purchase The Dark Report.

Artificial Intelligence: Now a Priority for Labs Read More »

Labs: Be Ready for Data to Dominate Diagnostics

By now, it should be clear to clinical lab managers and pathologists that the game in diagnostics is shifting. Traditionally, lab managers considered a primary goal to be the reporting of accurate test results within the target turnaround times. Going forward, that will no longer be enough. Instead, labs will be rewarded for taking lab

To access this post, you must purchase The Dark Report.

Labs: Be Ready for Data to Dominate Diagnostics Read More »

Most IVD Firms Increase Q3 2023 Base Business Revenue

Most in vitro diagnostics (IVD) companies reported increases in base business during the third quarter (Q3) 2023. The numbers, in the single digits, softened the blow from the continuing drop-off in COVID-19 test sales. Manufacturers of tests and laboratory instruments are launching new diagnostics solutions, making greater use of technology, and eyeing possible acquisitions as

To access this post, you must purchase The Dark Report.

Most IVD Firms Increase Q3 2023 Base Business Revenue Read More »

;